Target intelligence / Profile preview

ANKRD49 pseudogene 3 (ANKRD49P3)

Target
ANKRD49P3
Molecular classification
Other (Pseudogene)
01

Overview

ANKRD49 pseudogene 3 is classified as a pseudogene, meaning it is a nonfunctional genomic sequence with homology to the protein-coding ankyrin repeat domain 49 (ANKRD49) gene. Pseudogenes do not encode functional proteins and are generally not considered therapeutic targets. There is no evidence that ANKRD49P3 is involved in biological functions, human disease, or responses to drugs. Pseudogenes may occasionally be transcribed, but evidence for ANKRD49P3-specific transcription or function is lacking[4][5].\nThe ANKRD49 gene (not ANKRD49P3) encodes ankyrin repeat domain 49 and has described functions in transcriptional regulation and potential involvement in cancer[1][2][3]; however, the pseudogene ANKRD49P3 does not share these functional properties.

02

Biological functions

None established; pseudogenes generally lack biological functions, though rare transcription may occur[5]
03

Disease associations

None established; no direct disease role, since the gene is a pseudogene and not known to be transcribed or translated[4][5]

Beyond the preview

Go deeper on ANKRD49 pseudogene 3 (ANKRD49P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD49 pseudogene 3 (ANKRD49P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call